Skip to main content

Publisher: Elsevier

Volume 9, Number 15, 2 August 1999

Novel conformationally restricted tetracyclic analogs of Δ8-tetrahydrocannabinol
pp. 2119-2124(6)
Authors: Khanolkar, A.D.; Lu, D.; Fan, P.; Tian, X.; Makriyannis, A.

Favourites:
ADD

On-resin macrocyclization of peptides via intramolecular SnAr reactions
pp. 2125-2130(6)
Authors: Fotsch, C.; Kumaravel, G.; Sharma, S.K.; Wu, A.D.; Gounarides, J.S.; Nirmala, N.R.; Petter, R.C.

Favourites:
ADD

9-Deoxopodophyllotoxin derivatives as anti-cancer agents
pp. 2131-2134(4)
Authors: Subrahmanyam, D.; Renuka, B.; Kumar, G.S.; vandana, V.; deevi, D.S.

Favourites:
ADD

Practical synthesis of all inositol stereoisomers from myo-inositol
pp. 2135-2140(6)
Authors: Chung, S.; Kwon, Y.

Favourites:
ADD

Formation of 8-oxo-7,8-dihydro-2'-deoxyguanosine under anaerobic conditions by reductively activated nitro 5-deazaflavin derivatives
pp. 2141-2144(4)
Authors: Mikata, Y.; Kishigami, M.; Nishida, M.; Yano, S.; Kawamoto, T.; Ikeuchi, Y.; Yoneda, F.

Favourites:
ADD

Highly sequence selective nonmacrocyclic two-armed receptors for peptides
pp. 2145-2150(6)
Authors: Iorio, E.J.; Still, W.C.

Favourites:
ADD

Structure-activity relationship of N-methyl-N-aralkyl-peptidylamines as novel N-type calcium channel blockers
pp. 2151-2156(6)
Authors: Hu, L.; Ryder, T.R.; Rafferty, M.F.; Dooley, D.J.; Geer, J.J.; Lotarski, S.M.; Miljanich, G.P.; Millerman, E.; Rock, D.M.; Stoehr, S.J.; Szoke, B.G.; Taylor, C.P.; Vartanian, M.G.

Favourites:
ADD

Casein kinase II inhibitors isolated from two Brazilian plants Hymenaea parvifolia and Wulffia baccata
pp. 2157-2160(4)
Authors: Ishibashi, M.; Oda, H.; Mitamura, M.; Okuyama, E.; Komiyama, K.; Kawaguchi, K.; Watanabe, T.; Alves, S.d.M.; Maekawa, T.; Ohtsuki, K.

Favourites:
ADD
Favourites:
ADD

Derivatives of (R)-2-amino-5-methoxytetralin: Antagonists and Inverse Agonists at the Dopamine D2A Receptor
pp. 2167-2172(6)
Authors: Hook, B.B.; Brege, C.; Linnanen, T.; Mikaels, A.; Malmberg, A.; Johansson, A.M.

Favourites:
ADD

Synthesis of heterocyclic enol ethers and their use as group 2 metabotropic glutamate receptor antagonists
pp. 2173-2176(4)
Authors: Kolczewski, S.; Adam, G.; Stadler, H.; Mutel, V.; Wichmann, J.; Woltering, T.

Favourites:
ADD

Novel quinolizidine salicylamide influenza fusion inhibitors
pp. 2177-2180(4)
Authors: Yu, K.; Ruediger, E.; Luo, G.; Cianci, C.; Danetz, S.; Tiley, L.; Trehan, A.K.; Monkovic, I.; Pearce, B.; Martel, A.; Krystal, M.; Meanwell, N.A.

Favourites:
ADD

Dimethyldioxirane epoxidation of polycyclic fluoranthene hydrocarbons
pp. 2181-2184(4)
Authors: Liu, F.; Cho, B.P.

Favourites:
ADD

Design of peptides derived from anti-IgE antibody for allergic treatment
pp. 2185-2188(4)
Authors: Takahashi, M.; Ohgitani, Y.; Ueno, A.; Mihara, H.

Favourites:
ADD

Structure-based design of irreversible, tripeptidyl human rhinovirus 3C protease inhibitors containing N-methyl amino acids
pp. 2189-2194(6)
Authors: Dragovich, P.S.; Webber, S.E.; Prins, T.J.; Zhou, R.; Marakovits, J.T.; Tikhe, J.G.; Fuhrman, S.A.; Patick, A.K.; Matthews, D.A.; Ford, C.E.; Brown, E.L.; Binford, S.L.; Meador, J.W.; Ferre, R.A.; Worland, S.T.

Favourites:
ADD

Novel quinolinequinone antitumor agents: structure-metabolism studies with NAD(P)H:quinone oxidoreductase (NQO1)
pp. 2195-2198(4)
Authors: Fryatt, T.; Goroski, D.T.; Nilson, Z.D.; Moody, C.J.; Beall, H.D.

Favourites:
ADD

Human chymase inhibitors based on the 1,2,5-thiadiazolidin-3-one 1,1 dioxide scaffold
pp. 2199-2204(6)
Authors: Groutas, W.C.; Schechter, N.M.; He, S.; Yu, H.; Huang, P.; Tu, J.

Favourites:
ADD

Synthesis of pyrazolidinone antibacterial agents
pp. 2205-2206(2)
Authors: Couloigner, E.; Cartier, D.; Labia, R.

Favourites:
ADD

SAR in the alkoxy lactone series: the discovery of DFP, a potent and orally active cox-2 inhibitor
pp. 2207-2212(6)
Authors: Leblanc, Y.; Roy, P.; Boyce, S.; Brideau, C.; Chan, C.C.; Charleson, S.; Gordon, R.; Grimm, E.; Guay, J.; Leger, S.; Li, C.S.; Riendeau, D.; Visco, D.; Wang, Z.; Webb, J.; Xu, L.J.; Prasit, P.

Favourites:
ADD
Favourites:
ADD

Nonpeptidic HIV protease inhibitors: 6-alkyl-5,6-dihydropyran-2-ones possessing a novel and achiral 3-(2-t-butyl-5-methyl-4-sulfamate)phenylthio moiety
pp. 2217-2222(6)
Authors: Prasad, J.V.N.V.; Markoski, L.J.; Boyer, F.E.; Domagala, J.M.; Ellsworth, E.L.; Gajda, C.; Hagen, S.E.; Tait, B.D.; Lunney, E.A.; Tummino, P.J.; Ferguson, D.; Holler, T.; Hupe, D.; Nouhan, C.; Gracheck, S.J.; vanderRoest, S.; Saunders, J.; Iyer, K.; Sinz, M.

Favourites:
ADD

Triterpene and diterpene inhibitors of pyruvate dehydrogenase kinase (PDK)
pp. 2223-2228(6)
Authors: Aicher, T.D.; Damon, R.E.; Koletar, J.; Vinluan, C.C.; Brand, L.J.; Gao, J.; Shetty, S.S.; Kaplan, E.L.; Mann, W.R.

Favourites:
ADD

7-Amino-4-methyl-6-sulfocoumarin-3-acetic acid: a novel blue fluorescent dye for protein labeling
pp. 2229-2232(4)
Authors: Leung, W.; Trobridge, P.A.; Haugland, R.P.; Haugland, R.P.; Mao, F.

Favourites:
ADD

3-Alkyl-(5,5'-diphenyl)imidazolidinediones as new cannabinoid receptor ligands
pp. 2233-2236(4)
Authors: Kanyonyo, M.; Govaerts, S.J.; Hermans, E.; Poupaert, J.H.; Lambert, D.M.

Favourites:
ADD

Binding of Zn(II), Cu(II), and Fe(II) ions to alzheimer's a peptide studied by fluorescence
pp. 2243-2248(6)
Authors: Garzon-Rodriguez, W.; Yatsimirsky, A.K.; Glabe, C.G.

Favourites:
ADD

Photonuclease activity of Taylor's blue
pp. 2249-2254(6)
Authors: Mohammad, T.; Morrison, H.

Favourites:
ADD

Targeting nitric oxide to cancer cells: cytotoxicity studies of glyco-S-nitrosothiols
pp. 2255-2258(4)
Authors: Hou, Y.; Wang, J.; Andreana, P.R.; Cantauria, G.; Tarasia, S.; Sharp, L.; Braunschweiger, P.G.; Wang, P.G.

Favourites:
ADD

Increased antiviral activity of cyclic urea HIV protease inhibitors by modifying the P1/P1' substituents
pp. 2259-2262(4)
Authors: Kaltenbach, R.F.; Klabe, R.M.; Cordova, B.C.; Seitz, S.P.

Favourites:
ADD

Ring E analogs of methyllycaconitine (MLA) as novel nicotinic antagonists
pp. 2263-2266(4)
Authors: Bergmeier, S.C.; Lapinsky, D.J.; Free, R.B.; McKay, D.B.

Favourites:
ADD

Significant compensatory role of position Y-2 conferring high affinity to non-phosphorylated inhibitors of GRB2-SH2 domain
pp. 2267-2272(6)
Authors: Long, Y.; Voigt, J.H.; Lung, F.; King, C.R.; Roller, P.P.

Favourites:
ADD

Synthesis and biological evaluation of a new class of vaccine adjuvants: aminoalkyl glucosaminide 4-phosphates (AGPs)
pp. 2273-2278(6)
Authors: Johnson, D.A.; Sowell, C.G.; Johnson, C.L.; Livesay, M.T.; Keegan, D.S.; Rhodes, M.J.; Ulrich, J.T.; Ward, J.R.; Cantrell, J.L.; Brookshire, V.G.

Favourites:
ADD

Novel protein kinase C inhibitors: synthesis and PKC inhibition of -substituted polythiophene derivatives
pp. 2279-2282(4)
Authors: Xu, W.; Zhou, Q.; Ashendel, C.L.; Chang, C.; Chang, C.

Favourites:
ADD

Total synthesis of the potent proteasome inhibitor epoxomicin: a useful tool for understanding proteasome biology
pp. 2283-2288(6)
Authors: Sin, N.; Kim, K.B.; Elofsson, M.; Meng, L.; Auth, H.; Kwok, B.H.B.; Crews, C.M.

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more